Cargando…

Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD

BACKGROUND AND AIMS: Current understanding of histone post-translational modifications [histone modifications] across immune cell types in patients with inflammatory bowel disease [IBD] during remission and flare is limited. The present study aimed to quantify histone modifications at a single-cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Lawrence, Dermadi, Denis, Kalesinskas, Laurynas, Dvorak, Mai, Chang, Sarah E, Ganesan, Ananthakrishnan, Rubin, Samuel J S, Kuo, Alex, Cheung, Peggie, Donato, Michele, Utz, Paul J, Habtezion, Aida, Khatri, Purvesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155749/
https://www.ncbi.nlm.nih.gov/pubmed/36571819
http://dx.doi.org/10.1093/ecco-jcc/jjac194
_version_ 1785036397311164416
author Bai, Lawrence
Dermadi, Denis
Kalesinskas, Laurynas
Dvorak, Mai
Chang, Sarah E
Ganesan, Ananthakrishnan
Rubin, Samuel J S
Kuo, Alex
Cheung, Peggie
Donato, Michele
Utz, Paul J
Habtezion, Aida
Khatri, Purvesh
author_facet Bai, Lawrence
Dermadi, Denis
Kalesinskas, Laurynas
Dvorak, Mai
Chang, Sarah E
Ganesan, Ananthakrishnan
Rubin, Samuel J S
Kuo, Alex
Cheung, Peggie
Donato, Michele
Utz, Paul J
Habtezion, Aida
Khatri, Purvesh
author_sort Bai, Lawrence
collection PubMed
description BACKGROUND AND AIMS: Current understanding of histone post-translational modifications [histone modifications] across immune cell types in patients with inflammatory bowel disease [IBD] during remission and flare is limited. The present study aimed to quantify histone modifications at a single-cell resolution in IBD patients during remission and flare and how they differ compared to healthy controls. METHODS: We performed a case-control study of 94 subjects [83 IBD patients and 11 healthy controls]. IBD patients had either ulcerative colitis [n = 38] or Crohn’s disease [n = 45] in clinical remission or flare. We used epigenetic profiling by time-of-flight [EpiTOF] to investigate changes in histone modifications within peripheral blood mononuclear cells from IBD patients. RESULTS: We discovered substantial heterogeneity in histone modifications across multiple immune cell types in IBD patients. They had a higher proportion of less differentiated CD34(+) haematopoietic progenitors, and a subset of CD56(bright) natural killer [NK] cells and γδ T cells characterized by distinct histone modifications associated with gene transcription. The subset of CD56(bright) NK cells had increases in several histone acetylations. An epigenetically defined subset of NK cells was associated with higher levels of C-reactive protein in peripheral blood. CD34(+) monocytes from IBD patients had significantly decreased cleaved H3T22, suggesting they were epigenetically primed for macrophage differentiation. CONCLUSION: We describe the first systems-level quantification of histone modifications across immune cells from IBD patients at a single-cell resolution, revealing the increased epigenetic heterogeneity that is not possible with traditional ChIP-seq profiling. Our data open new directions in investigating the association between histone modifications and IBD pathology using other epigenomic tools.
format Online
Article
Text
id pubmed-10155749
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101557492023-05-04 Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD Bai, Lawrence Dermadi, Denis Kalesinskas, Laurynas Dvorak, Mai Chang, Sarah E Ganesan, Ananthakrishnan Rubin, Samuel J S Kuo, Alex Cheung, Peggie Donato, Michele Utz, Paul J Habtezion, Aida Khatri, Purvesh J Crohns Colitis Original Articles BACKGROUND AND AIMS: Current understanding of histone post-translational modifications [histone modifications] across immune cell types in patients with inflammatory bowel disease [IBD] during remission and flare is limited. The present study aimed to quantify histone modifications at a single-cell resolution in IBD patients during remission and flare and how they differ compared to healthy controls. METHODS: We performed a case-control study of 94 subjects [83 IBD patients and 11 healthy controls]. IBD patients had either ulcerative colitis [n = 38] or Crohn’s disease [n = 45] in clinical remission or flare. We used epigenetic profiling by time-of-flight [EpiTOF] to investigate changes in histone modifications within peripheral blood mononuclear cells from IBD patients. RESULTS: We discovered substantial heterogeneity in histone modifications across multiple immune cell types in IBD patients. They had a higher proportion of less differentiated CD34(+) haematopoietic progenitors, and a subset of CD56(bright) natural killer [NK] cells and γδ T cells characterized by distinct histone modifications associated with gene transcription. The subset of CD56(bright) NK cells had increases in several histone acetylations. An epigenetically defined subset of NK cells was associated with higher levels of C-reactive protein in peripheral blood. CD34(+) monocytes from IBD patients had significantly decreased cleaved H3T22, suggesting they were epigenetically primed for macrophage differentiation. CONCLUSION: We describe the first systems-level quantification of histone modifications across immune cells from IBD patients at a single-cell resolution, revealing the increased epigenetic heterogeneity that is not possible with traditional ChIP-seq profiling. Our data open new directions in investigating the association between histone modifications and IBD pathology using other epigenomic tools. Oxford University Press 2022-12-26 /pmc/articles/PMC10155749/ /pubmed/36571819 http://dx.doi.org/10.1093/ecco-jcc/jjac194 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Articles
Bai, Lawrence
Dermadi, Denis
Kalesinskas, Laurynas
Dvorak, Mai
Chang, Sarah E
Ganesan, Ananthakrishnan
Rubin, Samuel J S
Kuo, Alex
Cheung, Peggie
Donato, Michele
Utz, Paul J
Habtezion, Aida
Khatri, Purvesh
Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD
title Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD
title_full Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD
title_fullStr Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD
title_full_unstemmed Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD
title_short Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD
title_sort mass-cytometry-based quantification of global histone post-translational modifications at single-cell resolution across peripheral immune cells in ibd
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155749/
https://www.ncbi.nlm.nih.gov/pubmed/36571819
http://dx.doi.org/10.1093/ecco-jcc/jjac194
work_keys_str_mv AT bailawrence masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd
AT dermadidenis masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd
AT kalesinskaslaurynas masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd
AT dvorakmai masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd
AT changsarahe masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd
AT ganesanananthakrishnan masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd
AT rubinsamueljs masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd
AT kuoalex masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd
AT cheungpeggie masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd
AT donatomichele masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd
AT utzpaulj masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd
AT habtezionaida masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd
AT khatripurvesh masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd